In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...
7h
Hosted on MSNCloudflare Stock Edges Lower As Piper Sandler Says Analyst Day Won't Be 'Thesis-Changing:' Retail's BearishShares of Cloudflare Inc. (NET) fell nearly 1% in after-market trade on Monday, extending the losses of 1.6% during the day’s ...
6h
Hosted on MSNPiper Sandler Upgrades ACNB (ACNB)Fintel reports that on March 3, 2025, Piper Sandler upgraded their outlook for ACNB (NasdaqCM:ACNB) from Neutral to ...
Tenaya intends to use the net proceeds from the offering to fund the ongoing and planned development of its clinical and ...
Leerink Partners and Piper Sandler are acting as joint bookrunning managers for the proposed offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results